Literature DB >> 24160479

The accuracy of predicting survival in individual patients with cancer.

Douglas Kondziolka1, Phillip V Parry, L Dade Lunsford, Hideyuki Kano, John C Flickinger, Susan Rakfal, Yoshio Arai, Jay S Loeffler, Stephen Rush, Jonathan P S Knisely, Jason Sheehan, William Friedman, Ahmad A Tarhini, Lanie Francis, Frank Lieberman, Manmeet S Ahluwalia, Mark E Linskey, Michael McDermott, Paul Sperduto, Roger Stupp.   

Abstract

OBJECT: Estimating survival time in cancer patients is crucial for clinicians, patients, families, and payers. To provide appropriate and cost-effective care, various data sources are used to provide rational, reliable, and reproducible estimates. The accuracy of such estimates is unknown.
METHODS: The authors prospectively estimated survival in 150 consecutive cancer patients (median age 62 years) with brain metastases undergoing radiosurgery. They recorded cancer type, number of brain metastases, neurological presentation, extracranial disease status, Karnofsky Performance Scale score, Recursive Partitioning Analysis class, prior whole-brain radiotherapy, and synchronous or metachronous presentation. Finally, the authors asked 18 medical, radiation, or surgical oncologists to predict survival from the time of treatment.
RESULTS: The actual median patient survival was 10.3 months (95% CI 6.4-14). The median physician-predicted survival was 9.7 months (neurosurgeons = 11.8 months, radiation oncologists = 11.0 months, and medical oncologist = 7.2 months). For patients who died before 10 months, both neurosurgeons and radiation oncologists generally predicted survivals that were more optimistic and medical oncologists that were less so, although no group could accurately predict survivors alive at 14 months. All physicians had individual patient survival predictions that were incorrect by as much as 12-18 months, and 14 of 18 physicians had individual predictions that were in error by more than 18 months. Of the 2700 predictions, 1226 (45%) were off by more than 6 months and 488 (18%) were off by more than 12 months.
CONCLUSIONS: Although crucial, predicting the survival of cancer patients is difficult. In this study all physicians were unable to accurately predict longer-term survivors. Despite valuable clinical data and predictive scoring techniques, brain and systemic management often led to patient survivals well beyond estimated survivals.

Entities:  

Mesh:

Year:  2013        PMID: 24160479     DOI: 10.3171/2013.9.JNS13788

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  32 in total

Review 1.  Emerging Trends in the Management of Brain Metastases from Non-small Cell Lung Cancer.

Authors:  Thomas M Churilla; Stephanie E Weiss
Journal:  Curr Oncol Rep       Date:  2018-05-07       Impact factor: 5.075

2.  Analysis of prognostic factors and comparison of prognostic index scores in patients with brain metastases after whole-brain radiotherapy.

Authors:  Judong Luo; Hong Zhu; Yiting Tang; Honglin Wang; Xifa Zhou; Xujing Lu; Shuyu Zhang; Yunhai Li
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial.

Authors:  Julia Furtner; Els Genbrugge; Thierry Gorlia; Martin Bendszus; Martha Nowosielski; Vassilis Golfinopoulos; Michael Weller; Martin J van den Bent; Wolfgang Wick; Matthias Preusser
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

Review 4.  Through the patient's eyes: the value of a comprehensive brain tumor center.

Authors:  Adam M Robin; Tobias Walbert; Tom Mikkelsen; Steven N Kalkanis; Jack Rock; Ian Lee; Mark L Rosenblum
Journal:  J Neurooncol       Date:  2014-07-16       Impact factor: 4.130

Review 5.  The biology of radiosurgery and its clinical applications for brain tumors.

Authors:  Douglas Kondziolka; Samuel M Shin; Andrew Brunswick; Irene Kim; Joshua S Silverman
Journal:  Neuro Oncol       Date:  2014-09-28       Impact factor: 12.300

6.  Prognostic value of pre- and post-treatment health-related quality of life in predicting survival of patients with brain metastases.

Authors:  Erin Wong; Leigha Rowbottom; May Tsao; Liying Zhang; Rachel McDonald; Cyril Danjoux; Elizabeth Barnes; Stephanie Chan; Edward Chow
Journal:  CNS Oncol       Date:  2017-04

7.  How palliative care professionals deal with predicting life expectancy at the end of life: predictors and accuracy.

Authors:  Sara Mandelli; Emma Riva; Mauro Tettamanti; Ugo Lucca; Davide Lombardi; Gianmaria Miolo; Simon Spazzapan; Rita Marson
Journal:  Support Care Cancer       Date:  2020-08-31       Impact factor: 3.603

8.  Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases.

Authors:  Yufei Liu; Brian M Alexander; Yu-Hui Chen; Margaret C Horvath; Ayal A Aizer; Elizabeth B Claus; Ian F Dunn; Alexandra J Golby; Mark D Johnson; Scott Friesen; Edward G Mannarino; Matthew Wagar; Fred L Hacker; Nils D Arvold
Journal:  J Neurooncol       Date:  2015-06-25       Impact factor: 4.130

9.  Cumulative intracranial tumour volume prognostic assessment: a new predicting score index for patients with brain metastases treated by stereotactic radiosurgery.

Authors:  Carmine Antonio Donofrio; Andrea Cavalli; Marco Gemma; Lucia Riccio; Alessandra Donofrio; Pietro Panni; Camillo Ferrari da Passano; Antonella Del Vecchio; Angelo Bolognesi; Riccardo Soffietti; Pietro Mortini
Journal:  Clin Exp Metastasis       Date:  2020-05-19       Impact factor: 5.150

10.  Accuracy of Oncologists' Life-Expectancy Estimates Recalled by Their Advanced Cancer Patients: Correlates and Outcomes.

Authors:  Jason Lambden; Baohui Zhang; Robert Friedlander; Holly G Prigerson
Journal:  J Palliat Med       Date:  2016-08-30       Impact factor: 2.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.